News

Search:
 Search

Latest News | 6 July 2012

Valeant, Lundbeck Warned for Leaving Warnings out of Promotional Video

0 Likes

US regulators have sent pharmaceutical manufacturer Valeant Pharmaceuticals an untitled letter after finding a promotion for its Huntington’s disease-treatment drug Xenazine omits “material facts,” Read More...


RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

New Regulatory Focus Apps for iPad and iPhone